Ray Dalio, founder of Bridgewater Associates, warns that increasing inequality in the US is paving the way for autocratic leadership. He criticizes business leaders for their silence on Trump’s policies and predicts dire economic consequences.
As Congress returns from recess, the looming government shutdown deadline and a push to release Epstein files create a tense atmosphere. Will bipartisan support save the day, or will political turmoil reign?
In a surprising post on Truth Social, Trump raises doubts about the Covid vaccines developed during his presidency, demanding transparency from drug companies amid ongoing CDC turmoil.
In a significant gathering, leaders from Russia, Iran, and India join Xi Jinping in Tianjin to forge alliances against the US. Discover the implications of this strategic meeting!
As U.S. warships head to the Caribbean, tensions rise in Venezuela. The Trump administration intensifies its stance against Maduro, raising concerns of possible intervention amidst a humanitarian crisis.
Sen. Bernie Sanders demands the resignation of HHS Secretary Robert F. Kennedy Jr. following chaos at the CDC, criticizing his anti-vaccine stance and calling for accountability in public health leadership.
In a historic airstrike, Israel targets Yemen's Houthi leadership, killing the prime minister and several ministers. This marks a significant escalation in the ongoing conflict as Yemen faces turmoil and retaliation looms.
Jim O’Neill steps in as acting CDC director, replacing Susan Monarez amid controversy over vaccine policies. With ties to RFK Jr. and a libertarian stance, will he advocate for public health or follow orders?
In a shocking turn of events, Spirit Aviation Holdings Inc. has filed for Chapter 11 bankruptcy for the second time in less than a year. With assets and liabilities ranging from $1 billion to $10 billion, the airline struggles to recover amidst ongoing negotiations with major stakeholders.
President Trump moves to cancel $4.9 billion in foreign aid using a rare pocket rescission, prompting legal challenges and bipartisan backlash. Democrats warn this could complicate funding negotiations.
